SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Amarillo BioSciences (AMAR) - Oral Interferon delivery sys
AMAR 3.240-11.5%Aug 10 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jack montgomery who wrote (187)3/5/1999 11:13:00 AM
From: Tomas  Read Replies (1) of 201
 
Jack,

Seeing as we have our own private thread. <gg>

The research I did way back in the "GM" days showed that the company had a future, in my humble opinion, and what appeared to be a good product. The staff was extremely research intensive and very detail oriented. I can remember when a news release came out with one or two (to me) insignificant mistakes, and it was changed to reflect the correct status.

Over the past two years of following the company, it has come to my attention that the management has not really cared too much for Wall Street. They were public, but that was about it. I can remember the company getting pretty irate back in the hype days. They were busy and they didn't have time for all the foolishness that was taking place.

It has been two years and they would appear anyway to be coming out into the light. So now the question is, in this day of anything.com stocks that scream to record highs, what will happen to little old AMAR once the word spreads.

Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext